Clinical Trial Update: Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating UMOD NKCC2 interaction on salt-sensitivity in hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hypertension

Drugs mentioned

• UMOD NKCC2 interaction therapy

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Cardiovascular Diseases, Hypertension | Phase 4 | Status: COMPLETED